Published in Gastroenterology on October 01, 1995
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest (2005) 4.26
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut (2001) 1.88
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun (2011) 1.44
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol (2011) 1.35
Whipple's disease: a macrophage disease. Clin Vaccine Immunol (2006) 1.34
Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut (2005) 1.30
Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol (2008) 1.18
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun (2005) 1.15
Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut (1997) 1.09
Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun (2003) 1.08
Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut (1998) 1.05
Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med (2000) 1.05
Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin Exp Immunol (2000) 0.96
Peripheral monocyte functions and activation in patients with quiescent Crohn's disease. PLoS One (2013) 0.86
Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am J Pathol (2001) 0.85
Endotoxin stimulates monocyte-endothelial cell interactions in mouse intestinal Peyer's patches and villus mucosa. Clin Exp Immunol (2004) 0.83
Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin Exp Immunol (2004) 0.82
Mucosal immunity in gut and lymphoid cell trafficking. Ann Vasc Dis (2012) 0.81
High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed Inflammatory Bowel Disease patients. Clin Exp Immunol (2016) 0.75
Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ (2007) 3.22
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology (1997) 3.00
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study. Aliment Pharmacol Ther (2012) 2.89
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia (2005) 2.21
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol (2000) 2.08
Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut (2007) 1.98
Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Dig Liver Dis (2001) 1.77
Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology (1995) 1.74
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br J Cancer (2011) 1.73
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma. Oncogene (2006) 1.69
Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun (2005) 1.66
Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC) Ital J Gastroenterol Hepatol (1997) 1.53
Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol (2001) 1.52
Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol (1985) 1.52
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut (2006) 1.47
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology (1996) 1.47
CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J (2000) 1.45
Immunology of hepatocellular carcinoma. Ital J Gastroenterol (1991) 1.44
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Dig Liver Dis (2007) 1.43
Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology (1999) 1.41
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. Ital J Gastroenterol Hepatol (1998) 1.37
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest (1996) 1.36
Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol (1999) 1.35
The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol (1988) 1.31
HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. Clin Exp Immunol (1987) 1.28
A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis (1994) 1.27
TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunol (2008) 1.26
Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis (2001) 1.26
A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. Endoscopy (2005) 1.26
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut (2005) 1.25
Immunoregulation in the gut: success and failures in human disease. Gut (2002) 1.25
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.22
Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes. Eur J Immunol (1993) 1.22
Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest (1996) 1.22
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22
Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. Virology (1999) 1.19
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology (1999) 1.17
Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis (2010) 1.17
Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr Mol Med (2012) 1.17
Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol (2000) 1.13
Ability of human colonic epithelium to express the 4F2 antigen, the common acute lymphoblastic leukemia antigen, and the transferrin receptor. Studies in inflammatory bowel disease and after in vitro exposure to different stimuli. Gastroenterology (1989) 1.12
HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol (1988) 1.08
Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology (1998) 1.07
TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol (2003) 1.06
Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol Biol Cell (2001) 1.05
Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. Int J Tissue React (1993) 1.04
Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy (2010) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology (1999) 1.01
HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses (1995) 1.01
Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol (1998) 1.00
Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol (1994) 1.00
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells. Cell Death Differ (2006) 0.99
Salivary specific IgG is a sensitive indicator of the humoral immune response to Helicobacter pylori. FEMS Immunol Med Microbiol (1995) 0.98
Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J Interferon Res (1994) 0.98
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission. Gut (1997) 0.98
Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Am J Gastroenterol (1995) 0.98
In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. Gut (1981) 0.97
Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test. Curr Med Res Opin (2000) 0.96
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. J Crohns Colitis (2010) 0.96
Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol (1988) 0.96
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut (2004) 0.96
Paranasal sinuses anatomic variants: 64-slice CT evaluation. Minerva Stomatol (2007) 0.95
Epithelial cells and expression of the phagocytic marker CD68: scavenging of apoptotic bodies following Rho activation. Toxicol In Vitro (2002) 0.95
Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. AIDS Res Hum Retroviruses (1993) 0.95
Studies of peripheral blood lymphocytes in Crohn's disease. Circulating activated T cells. Scand J Gastroenterol (1983) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Review article: monitoring the activity of Crohn's disease. Aliment Pharmacol Ther (2002) 0.94
Murine granulocytes control human tumor growth in SCID mice. Int J Cancer (2000) 0.93
Prevalence, clinical features, and acute course of atypical myocardial infarction. Angiology (1994) 0.92
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7. Gut (1998) 0.92
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathologic features. J Pediatr Gastroenterol Nutr (1999) 0.91
Melanosis of the rectum in patients with chronic constipation. Dis Colon Rectum (1985) 0.91
The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine (1998) 0.91
Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci (2000) 0.91
Platelet hyperfunction in patients with chronic airways obstruction. Eur J Respir Dis (1985) 0.90
T cell early activation antigens expressed by peripheral lymphocytes in Crohn's disease. J Clin Lab Immunol (1985) 0.90